215 related articles for article (PubMed ID: 30350190)
1. Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis.
Fakiha K; Coller JK; Logan RM; Gibson RJ; Bowen JM
Support Care Cancer; 2019 Jun; 27(6):2313-2320. PubMed ID: 30350190
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity.
Tam JSY; Crame EE; Elz AS; Coller JK; Wignall A; Prestidge CA; Bowen JM
Cancer Chemother Pharmacol; 2022 Sep; 90(3):267-278. PubMed ID: 35962138
[TBL] [Abstract][Full Text] [Related]
3. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation.
Sun M; Zhan H; Long X; Alsayed AM; Wang Z; Meng F; Wang G; Mao J; Liao Z; Chen M
Phytomedicine; 2024 Jun; 128():155371. PubMed ID: 38518649
[TBL] [Abstract][Full Text] [Related]
4. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
[TBL] [Abstract][Full Text] [Related]
5. Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats.
Gibson RJ; Stringer AM; Bowen JM; Logan RM; Yeoh AS; Burns J; Alvarez E; Keefe DM
Cancer Biol Ther; 2007 Apr; 6(4):541-7. PubMed ID: 17457046
[TBL] [Abstract][Full Text] [Related]
6. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
[TBL] [Abstract][Full Text] [Related]
7. Banxia Xiexin decoction combined with 5-ASA protects against CPT-11-induced intestinal dysfunction in rats via inhibiting TLR4/NF-κB signaling pathway.
Zou Y; Wang Y; Zhou W; Pei J
Immun Inflamm Dis; 2024 Jun; 12(6):e1208. PubMed ID: 38860759
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota.
Bai X; Deng J; Duan Z; Fu R; Zhu C; Fan D
Phytomedicine; 2024 Jun; 128():155577. PubMed ID: 38608488
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.
Gibson RJ; Bowen JM; Inglis MR; Cummins AG; Keefe DM
J Gastroenterol Hepatol; 2003 Sep; 18(9):1095-100. PubMed ID: 12911669
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.
Wu Y; Wang D; Yang X; Fu C; Zou L; Zhang J
Biomed Pharmacother; 2019 Jan; 109():2252-2261. PubMed ID: 30551482
[TBL] [Abstract][Full Text] [Related]
12. TU-100 exerts a protective effect against bacterial translocation by maintaining the tight junction.
Takasu C; Yismaw WG; Kurita N; Yoshikawa K; Kashihara H; Kono T; Shimada M
Surg Today; 2017 Oct; 47(10):1287-1294. PubMed ID: 28421347
[TBL] [Abstract][Full Text] [Related]
13. Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.
Gibson RJ; Bowen JM; Keefe DM
Int J Cancer; 2005 Sep; 116(3):464-70. PubMed ID: 15800945
[TBL] [Abstract][Full Text] [Related]
14. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.
Guabiraba R; Besnard AG; Menezes GB; Secher T; Jabir MS; Amaral SS; Braun H; Lima-Junior RC; Ribeiro RA; Cunha FQ; Teixeira MM; Beyaert R; Graham GJ; Liew FY
Mucosal Immunol; 2014 Sep; 7(5):1079-93. PubMed ID: 24424522
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
16. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
Takasuna K; Hagiwara T; Watanabe K; Onose S; Yoshida S; Kumazawa E; Nagai E; Kamataki T
Cancer Chemother Pharmacol; 2006 Oct; 58(4):494-503. PubMed ID: 16437251
[TBL] [Abstract][Full Text] [Related]
17. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Shengjiang Xiexin Decoction on the Repair of Damaged Rat Intestinal Mucosa after Irinotecan Chemotherapy].
Wang J; Jia LQ; Tan HY; Pan L; Yu LL; Deng B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1236-43. PubMed ID: 26677677
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
[TBL] [Abstract][Full Text] [Related]
20. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T
Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
